Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 347.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 4.00 (1.156%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 347.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement for sale of a portfolio of NPLs

15 Nov 2021 07:00

RNS Number : 3645S
Bank of Cyprus Holdings PLC
15 November 2021
 

 

 

Announcement

 

 

Agreement for sale of a portfolio of Non Performing Loans

 

Nicosia, 15 November 2021

 

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014.

 

 

Bank of Cyprus Holdings Public Limited Company ("BOC Holdings" and, together with its subsidiaries, the "Group") has reached an agreement with funds affiliated with Pacific Investment Management Company LLC ("PIMCO"), for the sale of a portfolio of Non Performing Loans (the "Portfolio") with a gross book value of €577 mn1, as well as real estate properties with a book value of €121 mn1 (known as "Helix 3", or the "Transaction"). The Portfolio has a contractual balance of €993 mn2 and it comprises c.20,000 loans, mainly to Retail clients. At completion, the Bank will receive gross cash consideration of c.€385 mn.

 

The Transaction represents another milestone in the delivery of one of the Group's core strategic objectives of improving asset quality through the reduction of NPEs. Pro forma for this Transaction, the Group's NPE ratio will be in single digit.

 

The Transaction reduces the stock of NPEs by 36%1 and the properties by 9%1. On a pro forma basis, in the first nine months of 2021 our NPE stock reduced by €2.2 bn1 to €0.9 bn1, and the NPE ratio to 8.6%1, including Helix 3, Helix 2 and organic reductions.

 

Overall, by completion, the Transaction is expected to have a total positive impact of 66 bps1 on the Group's CET 1 ratio and c.€21 mn on the Group's income statement. The impact of the Transaction on the Group's income statement for 3Q2021 is a net profit of c.€10 mn and a positive impact of 7 bps1 on the Group's CET 1 ratio.

 

The completion of the Transaction is currently estimated to occur in the first half of 2022 and remains subject to a number of conditions, including customary regulatory and other approvals.

 

The Portfolio and the real estate properties included in the Transaction will be transferred to a licensed Cypriot Credit Acquiring Company (the "CyCAC") by Bank of Cyprus Public Company Limited (the "Bank"). The shares of the CyCAC will then be acquired by certain funds affiliated with PIMCO.

 

Following a transitional period where servicing will be retained by the Bank, it is intended that the servicing of the Portfolio and the real estate properties included in the Transaction will be carried out by a third party servicer selected and appointed by the purchaser.

 

PIMCO is one of the world's premier fixed income investment managers. With its launch in 1971 in Newport Beach, California, PIMCO introduced investors to a total return approach to fixed income investing. In the 45+ years since, the firm continued to bring innovation and expertise to their partnership with clients seeking the best investment solutions. Today PIMCO has offices across the globe and 2,900+ professionals united by a single purpose: creating opportunities for investors in every environment. PIMCO is owned by Allianz SE, a leading global diversified financial services provider.

 

Panicos Nicolaou, Group Chief Executive Officer, commented:

 

"I am delighted to announce the signing for the disposal of Helix 3 today, a significant milestone in our de-risking strategy, allowing us to early achieve, by a year, our guidance for a single digit NPE ratio, in a capital accretive and profitable transaction.

 

We are reaching the end of a long journey that started in 2014. Overall, since the peak, we have now reduced the stock of NPEs by €14.1 bn3 or 94%3 to less than €1 bn3 and the NPE ratio by 54 percentage points3, from 63% to less than 9%3. 

 

We are pleased with the progress achieved on our medium term strategic objectives, and remain fully committed and on track to achieve an NPE ratio of 5%."

 

Morgan Stanley & Co. International plc and Interpath Advisory acted as financial advisors, Allen & Overy LLP acted as English legal advisors and Chryssafinis & Polyviou LLC acted as Cypriot legal advisors to the Bank in this Transaction.

 

For further information, please contact Investor Relations at investors@bankofcyprus.com

 

 

 

1 Based on the Group Financial Results for the six months ended 30 June 2021

2 As at the reference date of 31 May 2021 

3 Based on the Group Financial Results for the six months ended 30 June 2021, proforma for Helix 3 and the organic NPE reduction of c.€300 mn in the first nine months of 2021

 

 

 

 

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 91 branches in Cyprus, of which 11 operate as cash offices. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 3,558 staff worldwide. At 30 June 2021, the Group's Total Assets amounted to €24.2 bn and Total Equity was €2.1 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRUVVNRABUAARA
Date   Source Headline
8th May 20247:06 amRNSTransaction in Own Shares
2nd May 20247:28 amRNSBOCH - Transactions in Own Shares
2nd May 20247:20 amRNSBOCH – Total voting rights and Capital
30th Apr 202410:19 amRNSAppointments of New Directors
30th Apr 20247:02 amRNSTransaction in Own Shares
29th Apr 20247:15 amRNSBOCH - Transactions in Own Shares
26th Apr 20241:21 pmRNSDate of announcement of 1Q2024 FR
26th Apr 20247:03 amRNSBOCH - Transactions in Own Shares
25th Apr 20247:26 amRNSBOCH - Transactions in Own Shares
25th Apr 20247:00 amRNSIssue of Green Senior Preferred Notes by BOC PCL
24th Apr 20247:00 amRNSBOCH - Transaction in Own Shares
24th Apr 20247:00 amRNSTR1 Notification - Helikon
24th Apr 20247:00 amRNSTR1 Notification -Helikon
23rd Apr 20247:25 amRNSBOCH - Transactions in Own Shares
22nd Apr 20247:27 amRNSBOCH - Transactions in Own Shares
19th Apr 20247:41 amRNSLaunch of share buyback programme
12th Apr 202410:02 amRNSNotice of AGM
5th Apr 20247:20 amRNS2023 Pillar 3 Disclosures
2nd Apr 20241:21 pmRNSTR1 Notification of Holdings - OSOME
2nd Apr 202412:59 pmRNSTR1 Notification of Holdings - OSOME
28th Mar 20242:24 pmRNSBOC Annual Financial Report 2023 Announcement
28th Mar 20241:31 pmRNSBOCH Annual Financial Report 2023 Announcement
28th Mar 20241:30 pmRNSFY2023 Investor Presentation Announcement
28th Mar 20241:30 pmRNSFY2023 Group Financial Results
20th Mar 20247:00 amRNSAnnouncement of Distribution
15th Mar 20249:21 amRNSDate of Announcement of Audited FY2023 FS
19th Feb 20247:01 amRNSDoc re. (Prelim FY2023 Investor Presentation)
19th Feb 20247:00 amRNSPreliminary FY2023 Group Financial Results
6th Feb 20248:41 amRNSDate of announcement of Preliminary FY2023 FR
22nd Dec 20239:09 amRNSRevised Date of AGM
20th Dec 20238:32 amRNSChanges in the composition of the BOD & Committees
13th Dec 20237:00 amRNSEU-wide Transparency Exercise 2023
11th Dec 20232:51 pmRNSChanges in the composition of the BOD
29th Nov 202310:28 amRNSDecision to call AT1 Capital Securities
29th Nov 20238:19 amRNSDate of Annual General Meeting
20th Nov 20239:58 amRNSAppointment of New Director
13th Nov 20237:00 amRNSDoc re. (9M2023 Investor Presentation)
13th Nov 20237:00 amRNS9M2023 Group Financial Results
27th Oct 20237:17 amRNSDate of announcement of 9M2023 FR
24th Oct 202312:41 pmRNSTR1 Notification - Caius
13th Oct 202312:27 pmRNSChanges in the composition of the BODs
27th Sep 20238:28 amRNSDirectorate Change
31st Aug 20237:37 amRNSChanges in the composition of BOD
11th Aug 20239:55 amRNSAppointment of new director
21st Jul 202310:43 amRNSDate of announcement of 1H2023 FR
18th Jul 20234:43 pmRNSIssue of Senior Preferred Notes
3rd Jul 202311:48 amRNSBuyback of Additional Tier 1 Capital Securities
23rd Jun 202312:48 pmRNSComposition of the Boards of Directors
20th Jun 202312:22 pmRNSResults of Additional Tier 1 Tender Cash Offer
19th Jun 202312:34 pmRNSTR1 Notification of Major Holdings - Caius

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.